Catheter Precision Files 8-K on Operations & Financial Condition
Ticker: VTAK · Form: 8-K · Filed: Jan 11, 2024 · CIK: 1716621
| Field | Detail |
|---|---|
| Company | Catheter Precision, Inc. (VTAK) |
| Form Type | 8-K |
| Filed Date | Jan 11, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: financial-condition, operations, 8-K
TL;DR
**Catheter Precision just dropped an 8-K on its financials, so expect news on performance.**
AI Summary
Catheter Precision, Inc. filed an 8-K on January 11, 2024, reporting on events that occurred on January 10, 2024. This filing primarily covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' indicating that the company is likely providing an update on its financial performance or significant financial events. For investors, this matters because it provides crucial, timely information about the company's financial health and operational status, which can influence stock valuation and future investment decisions.
Why It Matters
This filing provides investors with an immediate update on Catheter Precision's financial performance and condition, which is critical for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: medium — The filing indicates an update on financial condition and operations, which could contain either positive or negative news, creating uncertainty for investors.
Analyst Insight
Investors should look for the specific details of the 'Results of Operations and Financial Condition' that this 8-K refers to, as they will provide the actual financial data and operational updates necessary for informed decision-making.
Key Players & Entities
- Catheter Precision, Inc. (company) — the registrant filing the 8-K
- January 10, 2024 (date) — date of the earliest event reported
- January 11, 2024 (date) — date the 8-K was filed
- 001-38677 (other) — Commission File Number
- 38-3661826 (other) — IRS Employer Identification No.
Forward-Looking Statements
- Catheter Precision will release detailed financial results or an operational update soon. (Catheter Precision, Inc.) — high confidence, target: 2024-01-31
FAQ
What is the primary purpose of this 8-K filing by Catheter Precision, Inc.?
The primary purpose of this 8-K filing, as indicated by the 'ITEM INFORMATION,' is to report on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' for Catheter Precision, Inc.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 10, 2024, as stated under 'Date of Report (Date of earliest event reported).'
What is the full business address of Catheter Precision, Inc. as listed in the filing?
The full business address of Catheter Precision, Inc. is 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708.
What is the telephone number for Catheter Precision, Inc.?
The telephone number for Catheter Precision, Inc. is (973) 691-2000.
Under which SEC Act is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934, as indicated in the filing.
Filing Stats: 531 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-01-11 16:15:46
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share VTAK NYSE American Indi
Filing Documents
- rmed_8k.htm (8-K) — 26KB
- rmed_ex991.htm (EX-99.1) — 16KB
- 0001654954-24-000467.txt ( ) — 167KB
- rmed-20240110.xsd (EX-101.SCH) — 6KB
- rmed-20240110_lab.xml (EX-101.LAB) — 14KB
- rmed-20240110_cal.xml (EX-101.CAL) — 1KB
- rmed-20240110_pre.xml (EX-101.PRE) — 9KB
- rmed-20240110_def.xml (EX-101.DEF) — 2KB
- rmed_8k_htm.xml (XML) — 4KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 10, 2024, Catheter Precision, Inc. (formerly known as Ra Medical Systems, Inc.) (the "Company") issued a press release announcing its unaudited preliminary fourth quarter and full year 2023 results. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02 and in Exhibit 99.1 attached hereto is being "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended. The information in this current report shall be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof, that incorporates by reference documents filed by the Company with the Securities and Exchange Commission.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release Issued on January 10, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: January 11, 2024 By: /s/ Margrit Thomassen Margrit Thomassen Interim Chief Financial Officer and Secretary 3